Search Results 1061-1070 of 17954 for sickle cell

  1. Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes - Mayo Clinic

    mayo-mobile-logo-image. Menu; Search. Search. All Mayo Clinic Topics. Care at ... Known history of hemoglobinopathy, hemolytic anemia or sickle cell anemia ...

  2. Clinical trials - Oncology (Medical)

    Tissue microarray and immunohistochemical (IHC) analysis will also be performed on cell lines, PDX and patient tissues to identify potential molecular targets ...

  3. Oncology (Medical) - Clinical trials

    The collected tissue specimens will be used to develop preclinical models; i.e., cell lines, patient derived micro-cancer models as well as patient-derived ...

  4. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers report finding a new technique to tag senescent cells. Latest stories. Medications underused in treating opioid addiction, Mayo ...

  5. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Could CAR-T cell therapy improve kidney transplants? · Mayo Clinic, Terasaki Institute launch collaboration for transplant innovation featured ...

  6. Medical Research & Education - Mayo Clinic News Network

    D. September 17, 2024. More Mayo neuroscience: Brain cells 'crosstalk' and cancer growth; ...

  7. Medical Research & Education - Mayo Clinic News Network

    Marla Broadfoot, Ph.D. September 17, 2024. More Mayo neuroscience: Brain cells 'crosstalk' and cancer ...

  8. Neurology - Clinical trials

    Rochester, Minn. The purpose of this research is to develop stem cells from cells within patients' skin in order to better understand peripheral neuropathy and ...

  9. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...

  10. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...